Cannon Financial Strategists’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cannon Financial Strategists's LLY Position: Q2 2026 in Review
Cannon Financial Strategists reduced its Eli Lilly (LLY) stake by 0.56% in Q2 2026, selling an estimated $2.04K and leaving 354 shares worth $425K. The position accounts for 0.05% of the portfolio, ranked #85.
Cannon Financial Strategists first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,640 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cannon Financial Strategists held 354 shares of Eli Lilly worth $425K as of Q2 2026.
- Cannon Financial Strategists sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
- Eli Lilly made up 0.05% of Cannon Financial Strategists's portfolio in Q2 2026, its #85 holding.
- Cannon Financial Strategists first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,640 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cannon Financial Strategists's 13F filing for Q2 2026, filed 7 Aug 2026.